Lv4
675 积分 2021-06-01 加入
Zbtb32 promotes CD8+ T cell differentiation and function in cancer
1个月前
已关闭
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
1个月前
已完结
Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer
1个月前
已完结
PARP inhibition generates enhanced CD8+ central memory T cells by transcriptional and metabolic reprogramming
1个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
1个月前
已完结
Inavolisib-Based Therapy in PIK3CA -Mutated Advanced Breast Cancer
2个月前
已完结
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer
3个月前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
4个月前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
4个月前
已完结
Mannose metabolism reshapes T cell differentiation to enhance anti-tumor immunity
4个月前
已完结
皖公网安备34019202002308
